Concepedia

Merve Mutlu

MM

Statistics

Publications

8

Citations

363

H-Index

8

Active since

2014

Affiliations

The Netherlands Cancer Institute(Current)

Novartis (Switzerland)

University of Bern

Bilkent University

Oncode Institute

Merve Mutlu is an author at The Netherlands Cancer Institute specializing in oncology, life sciences, and cancer biology.

Publications per year

2014–2024

8

Publications

8

Heterozygous Deep-Intronic Variants and Deletions in<i>ABCA4</i>in Persons with Retinal Dystrophies and One Exonic<i>ABCA4</i>Variant

Nathalie M. Bax, Riccardo Sangermano, Susanne Roosing et al. · Human Mutation · 2014 · 77 citations

Life Sciences, Genetics, Molecular Genetics +17

miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer

Merve Mutlu, Özge Saatci, Suhail A. Ansari et al. · Scientific Reports · 2016 · 74 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer

Umar Raza, Özge Saatci, Stefan Uhlmann et al. · Oncotarget · 2016 · 59 citations · Full text

Medicine, Cancer Biology, Oncology +16

Functional Radiogenetic Profiling Implicates ERCC6L2 in Non-homologous End Joining

Paola Francica, Merve Mutlu, Vincent A. Blomen et al. · Cell Reports · 2020 · 52 citations · Full text

Medicine, Cancer Biology, Oncology +17

Dual BACH1 regulation by complementary SCF-type E3 ligases

Benedikt Goretzki, Maryam Khoshouei, Martin Schröder et al. · Cell · 2024 · 32 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +10

1–5 of 8